GENE ONLINE|News &
Opinion
Blog

Anti-PD-1
Global Expansion between Europe and India of Novel anti-PD-1 mAb Serplulimab
2023-10-31
2023 ASCO Annual Meeting: Progress in Solid Tumor Treatment Research, and Promising Results in Emerging Therapies
2023-07-03
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
EU Expands Merck’s Keytruda Use on Breast Cancer
2022-05-25
FDA Accepts BeiGene’s BLA for Esophageal Cancer Drug
2021-09-14
Another Homegrown Anti-PD-1 Antibody Scores Regulatory Win in China
2021-08-31
Chinese Regulator Accepts BeiGene’s Tislelizumab sBLA for Nasopharyngeal Cancer
2021-08-23
Innovent Announces Gastric Cancer Trial Win for Tyvyt, Reveals Plans for Another China Approval
2021-08-16
Xilio Collaborates With Merck to Evaluate Combo of CTLA-4 and PD-1 Blockers Against Solid Tumors
2021-05-26
Merck’s Anti-PD1 Therapy Receives Second FDA Approval for Esophageal Carcinoma
2021-03-25
R&D
Merck Bets Big on Seattle Genetics for Two Oncology Drugs
2020-09-16
A Novel Tool to Augment Checkpoint Inhibitor Cancer Therapy
2020-08-19
The Influential Role of Gut Microbiome in Cancer Therapy
2020-08-06Partner
BioNTech to Test mRNA-Based Cancer Vaccine with Regeneron’s anti-PD1 Drug in Melanoma Patients
2020-08-04
R&D
AACR 2020: Modifications in Tumor Microenvironment and Host Microbiome, a Potential Therapeutic Strategy for Immunotherapy
2020-05-08
1 2
LATEST
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
2024-04-12
Vertex Pharmaceuticals Makes $4.9 Billion Bet on Kidney Disease Treatment through Alpine Immune Acquisition
2024-04-11
Bayer Signs New Partnership with Google Cloud, Joining Hands for AI Solutions for Radiologists
2024-04-10
Pharmacogenomics (PGx) Shaping the Dynamic APAC Regions
2024-04-10
Connecting Biotech Ecosystems: Success of Los Angeles Event Sets Stage for APAC-US Collaboration
2024-04-10
Innovating Prostate Cancer Care: SYNC-T, Proteogenomics, and Culturally Tailored Education at AACR 2024
2024-04-10
EVENT
Scroll to Top